Maravai LifeSciences Holdings Inc
(NAS:MRVI)
$
5.68
0.19 (3.46%)
Market Cap: 805.67 Mil
Enterprise Value: 1.03 Bil
PE Ratio: 0
PB Ratio: 2.33
GF Score: 72/100 Maravai LifeSciences Holdings Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 10, 2021 / 06:10PM GMT
Release Date Price:
$43.65
(+3.93%)
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst
Good afternoon, everyone. I'm Matt Sykes, the life science tools and diagnostics analyst at Goldman Sachs, and I have the pleasure of welcoming the management team from Maravai LifeSciences with us this afternoon. We have Carl Hull, the Chief Executive Officer; and Kevin Herde, the Chief Financial Officer. Carl, Kevin, thanks so much for joining us. I appreciate you having -- you guys coming here.
Carl W. Hull
Maravai LifeSciences Holdings, Inc. - Co-Founder, Chairman & CEO
Hey, Matt, it's good to see you.
Questions & Answers
Matthew Carlisle Sykes;Carl W. Hull
Goldman Sachs Group, Inc., Research Division - Research Analyst;Maravai
Great. Maybe Carl, I'll turn it over to you first, just to kind of set the stage a little bit for us. Talk about some of the key highlights of Maravai and what investors really should be top of mind for them as they continue to look at Maravai.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot